Israel Englander Jazz Pharmaceuticals PLC Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Millennium Management LLC holds 1,700 shares of JAZZ stock, worth $181,441. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,700

Previous 588,463 99.71%

Holding current value

$181,441

Previous $72.4 Million 99.72%

% of portfolio

0.0%

Previous 0.03%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$115.19 - $132.77 $65.1 Million - $75 Million	-564,837 Reduced 95.99%	23,626 $2.85 Million
Q4 2023 Feb 14, 2024	BUY	$114.26 - $136.0 $2.76 Million - $3.29 Million	24,176 Added 4.28%	588,463 $72.4 Million
Q2 2023 Aug 14, 2023	SELL	$122.5 - $147.16 $77.3 Million - $92.9 Million	-631,294 Reduced 52.8%	564,287 $70 Million
Q1 2023 May 15, 2023	BUY	$133.98 - $160.47 $96.4 Million - $115 Million	719,435 Added 151.1%	1,195,581 $175 Million
Q4 2022 Feb 14, 2023	SELL	$129.72 - $159.85 $10.2 Million - $12.6 Million	-78,908 Reduced 14.22%	476,146 $75.9 Million

Q3 2022 Nov 14, 2022	SELL	$126.59 - $161.18 $20.9 Million - $26.6 Million	-165,076 Reduced 22.92%	555,054 $74 Million
Q2 2022 Aug 15, 2022	SELL	$141.59 - $168.66 $12.4 Million - $14.8 Million	-87,519 Reduced 10.84%	720,130 $112 Million
Q1 2022 May 16, 2022	BUY	$129.64 - $160.7 $47.6 Million - $59 Million	366,842 Added 83.22%	807,649 $126 Million
Q4 2021 Feb 14, 2022	BUY	$119.87 - $145.67 $52.8 Million - $64.2 Million	440,807 New	440,807 $56.2 Million
Q3 2021 Nov 15, 2021	SELL	$128.64 - $184.79 $3.37 Million - $4.85 Million	-26,229 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$160.2 - $186.42 $3.92 Million - $4.56 Million	24,460 Added 1382.7%	26,229 $4.66 Million
Q1 2021 May 17, 2021	SELL	$150.19 - $173.5 $17.4 Million - $20.1 Million	-115,938 Reduced 98.5%	1,769 $291,000
Q4 2020 Feb 16, 2021	SELL	$140.71 - $165.05 $19.3 Million - $22.6 Million	-137,105 Reduced 53.81%	117,707 $19.4 Million
Q3 2020 Nov 16, 2020	SELL	$105.46 - $144.13 $28.7 Million - $39.3 Million	-272,517 Reduced 51.68%	254,812 $36.3 Million
Q2 2020 Aug 14, 2020	BUY	$95.68 - $121.88 $46.1 Million - $58.7 Million	481,896 Added 1060.67%	527,329 $58.2 Million
Q1 2020 May 14, 2020	SELL	$87.74 - $152.74 $29,129 - $50,709	-332 Reduced 0.73%	45,433 $4.53 Million
Q4 2019 Feb 14, 2020	BUY	$117.65 - $153.73 $4.84 Million - $6.33 Million	41,157 Added 893.16%	45,765 $6.83 Million
Q3 2019 Nov 14, 2019	SELL	$125.18 - $143.24 $16.8 Million - $19.2 Million	-134,333 Reduced 96.68%	4,608 $590,000
Q2 2019 Aug 15, 2019	SELL	$125.55 - $144.48 $448 Million - $515 Million	-3,565,809 Reduced 96.25%	138,941 $19.8 Million
Q2 2019 Aug 14, 2019	BUY	$125.55 - $144.48 $449 Million - $517 Million	3,580,008 Added 2869.93%	3,704,750 $42.9 Million
Q1 2019 May 14, 2019	SELL	$121.81 - $142.95 $15.6 Million - $18.2 Million	-127,664 Reduced 50.58%	124,742 $17.8 Million
Q4 2018 Feb 14, 2019	BUY	$115.94 - $166.74 $16 Million - $23 Million	138,007 Added 120.64%	252,406 $31.3 Million
Q3 2018 Nov 14, 2018	BUY	$161.01 - $180.57 $18.4 Million - $20.7 Million	114,399 New	114,399 $19.2 Million
Q2 2018 Aug 14, 2018	SELL	$146.33 - $183.18 $32.3 Million - $40.4 Million	-220,639 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$135.59 - $157.16 $26.2 Million - $30.4 Million	193,347 Added 708.44%	220,639 $33.3 Million
Q4 2017 Feb 14, 2018	SELL	$131.06 - $150.39 $13.5 Million - $15.5 Million	-103,198 Reduced 79.08%	27,292 $3.68 Million
Q3 2017 Nov 14, 2017	BUY	$142.62 - $155.6 $18.6 Million - $20.3 Million	130,490	130,490 $19.1 Million

Others Institutions Holding JAZZ

# of Institutions

514

Shares Held

57.1M

Call Options Held

65.9K

Put Options Held

183K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $6.69B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account